| Gene/Event | Cancer Type | Patient | Variant | Mutation Level |
|---|---|---|---|---|
| TET2 | Bladder Cancer | p076_MSK-0754 | p.E294K | Trunk mutation |
| TET2 | Bladder Cancer | p084_p3 | - | Trunk mutation |
| TET2 | Breast Cancer | p111_p8-82 | p.E1357Q | Branch mutation |
| TET2 | Breast Cancer | p143_p5 | Chr4:106157384:A>G | Private mutation |
| TET2 | Osteosarcoma | p102_OS03 | Chr4:106197290:T>A | Branch mutation |
| TET2 | Colorectal Cancer | p001_PCRC12 | Chr4:106197633:A>T | Private mutation |
| TET2 | Colorectal Cancer | p014_CRC2 | p.H1382H | Trunk mutation |
| TET2 | Colorectal Cancer | p034_MSU4 | Chr4:106180785:C>T | Private mutation |
| TET2 | Colorectal Cancer | p069_p14 | p.Q373K | Trunk mutation |
| TET2 | Colorectal Cancer | p069_p17 | p.Q373K | Private mutation |
| TET2 | Colorectal Cancer | p075_p1 | p.E1151X | Branch mutation |
| TET2 | Endometrial Cancer | p042_EC007 | p.S838fs | Branch mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p124_ESCC012 | p.R1302T | Branch mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p124_ESCC022 | p.A289S | Trunk mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p128_P11 | Chr4:106157022:G>T | Private mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p128_SP14 | Chr4:106158370:A>G | Private mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p128_SP25 | Chr4:106162570:G>T | Private mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p128_SP27 | Chr4:106155895:C>A | Private mutation |
| TET2 | Esophageal Squamous Cell Carcinoma | p139_EC1020 | p.S1611Y | Private mutation |
| TET2 | Gastric Carcinoma | p106_GC09 | p.Y620H | Private mutation |
| TET2 | Glioblastoma | p113_case01 | p.R1516* | Private mutation |
| TET2 | Glioma | p168_P01 | p.L18L | Branch mutation |
| TET2 | Glioma | p168_P01 | p.D648D | Branch mutation |
| TET2 | Glioma | p168_P01 | p.T859I | Private mutation |
| TET2 | Hepatocellular Carcinoma | p061_P08 | Chr4:106155931:C>G | Branch mutation |
| TET2 | Lung Cancer | p028_RJLC4-T1 | p.A912V | Trunk mutation |
| TET2 | Lung Adenocarcinoma | p109_p1-9450 | p.A1045D | Trunk mutation |
| TET2 | Lung Adenocarcinoma | p109_p3-6610 | p.S1050X | Private mutation |
| TET2 | Non-Small Cell Lung Cancer | p148_p02 | p.R814S | Trunk mutation |
| TET2 | Non-Small Cell Lung Cancer | p148_p02 | p.K1338N | Private mutation |
| TET2 | Melanoma | p043_F | p.P1889S | Trunk mutation |
| TET2 | Melanoma | p043_H | p.V1199M | Private mutation |
| TET2 | Myeloma | p097_04 | - | Branch mutation |
| TET2 | Myeloma | p097_19 | - | Branch mutation |
| TET2 | Myeloma | p097_24 | - | Branch mutation |
| TET2 | Myeloma | p097_34 | - | Branch mutation |
| TET2 | Ovarian Cancer | p153_RJOC08 | p.I1762V | Private mutation |
| TET2 | Prostate Cancer | p118_CPCG0184 | p.I1762V | Branch mutation |
| TET2 | Prostate Cancer | p164_P1 | p.V218M | Branch mutation |
| TET2 | Prostate Cancer | p164_P2 | p.V218M | Branch mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p025_CCCFP2 | - | Trunk mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p025_CCCFP2 | - | Branch mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p025_CCCFP19 | - | Branch mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p025_CCCFP21 | - | Trunk mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p025_CCCFP29 | - | Trunk mutation |
| TET2 | Clear Cell Renal Cell Carcinoma | p121_p218 | p.D1142fs | Trunk mutation |
| TET2 | Renal Cell Carcinoma | p073_RCC3 | Chr4:106190972:C>T | Private mutation |
| TET2 | Renal Cell Carcinoma | p073_RCC4 | Chr4:106197262:T>C | Trunk mutation |
| TET2 | Urothelial Carcinoma | p142_p33 | - | Private mutation |